Myocardial Fibrosis by Late Gadolinium Enhancement Among Patients With Hypertrophic Cardiomyopathy

Key Points

• This research aims to assess myocardial fibrosis in patients with hypertrophic cardiomyopathy using late gadolinium enhancement.
• Conducted a randomized trial among patients with hypertrophic cardiomyopathy.
• Utilized late gadolinium enhancement cardiac imaging for fibrosis assessment.
• Analyzed the correlations between imaging results and clinical outcomes.
• Identified significant levels of myocardial fibrosis among patients, with a 40% prevalence rate.
• Late gadolinium enhancement predicted adverse clinical events with an HR of 2.5 (95% CI: 1.2-5.2, p=0.01).
• Improved risk stratification was observed in patients assessed with this imaging technique.